VGT (02476) plans a global offering of 83.348 million H shares, introducing cornerstone investors including CPE Rosewood and Janchor Fund.

FOSUN PHARMA (02196) announced that its Flurbiprofen Axetil Injection has received registration approval.

Henlius (02696) reported that the first patient in China has been dosed in the Phase 1 clinical study of its pertuzumab and trastuzumab injection (subcutaneous) biosimilar, HLX319.

Gaush Medical (02407) announced that its subsidiary, Gaush Innovation, has obtained the CE mark for a corneal confocal microscope.

Rongchang Biologics (09995) disclosed that the marketing application for disitamab vedotin, for the treatment of HER2-expressing urothelial carcinoma, has been approved.

Codi Biotech (02487) announced the completion of its Chinese Phase III clinical trial for CU-20101 (Botulinum Toxin Type A for Injection) aimed at improving moderate to severe glabellar lines.

Hengrui Pharmaceuticals (01276) announced that its HRS-5765 tablets have received approval for clinical trials.

LINMON MEDIA (09857) reported that the filming for "The Final Ten Days" commenced on April 10th, with the official cast announced.

SHUANGDENG (06960) is investing in a project for an annual production capacity of 12GWh semi-solid-state artificial intelligence data center (AIDC) energy storage battery cells and system integration.

In share repurchase and changes in holdings, Aoda Holdings (09929) controlling shareholder, Yaocapital, sold a 9% stake in the company, realizing $13.1754 million.

Cambridge Industries (06166) announced that its controlling shareholder intends to reduce its holding by no more than 9.4691 million shares in total.

Regarding operational performance, J&T EXPRESS-W (01519) reported a total parcel volume of 8.326 billion for the first quarter, representing a year-on-year increase of 26.2%.

Far East Horizon (03360) reported a slight year-on-year increase in both operating revenue and profit attributable to ordinary shareholders for the first quarter.

FriendTimes (01450) completed a Gross Merchandise Volume (GMV) of over RMB 3.17 billion in the first quarter.

C&D International (01908) reported cumulative contracted sales attributable to the company's equity holders of approximately RMB 19.31 billion for the first quarter, a decrease of 20.5% year-on-year.